Latest Breaking News On - Recent company - Page 1 : comparemela.com

Beam Global Announces Record First Quarter 2024 Operating Results

Beam Global Announces Record First Quarter 2024 Operating Results
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United kingdomNorth carolinaUnited statesSerbia generalSan diegoDesmond wheatleyUs national park serviceUnited kingdom ministry of defenseUs armyBeam europeBeam global pressRenewable energyBritish armyUs department of homeland securityNational mallCarolina department of adult correction

Avadel Reports Uptick in Lumryz Therapy Adoption for Narcolepsy

Avadel Reports Uptick in Lumryz Therapy Adoption for Narcolepsy
sleepreviewmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sleepreviewmag.com Daily Mail and Mail on Sunday newspapers.

Greg divisAvadel pharmaceuticalsDrug administrationSupplemental new drug applicationRecent company

Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Courtney mogerleyGreg divisLesley stanleyAvadel pharmaceuticalsStern investor relations incSecurities exchangeExchange commissionDrug administrationUs food drug administrationChief executive officerRecent companySupplemental new drug applicationFirst quarter financialCall detailsOrphan drug exclusivityPrescribing information

Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results

Company presented positive preliminary data from Phase 1 dose escalation portion of

United kingdomNorbert bischofbergerKronos bioSarah connorsBusiness developmentExchange commissionCorporate affairsCompany updatesCompany on linkedinKronos bio incRecent companyConnective tissue oncology society annual meetingCash equivalentsSan mateoPrivate securities litigation reform actQuarterly report

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results

$7.0 million in third quarter LUMRYZ™ net revenue from U.S. commercial launch Generated robust demand for LUMRYZ with greater than 1,000 patients enrolled in RYZUPTM and more than 400 patients initiating therapy as of September 30 LUMRYZ to be added to preferred position for CVS commercial formularies effective January 1, 2024 Submitted sNDA for LUMRYZ in pediatric narcolepsy population on November 7th Management to host a conference call today at 8:30 a.m. ET DUBLI

Courtney turianoGreg divisLesley stanleyAvadel pharmaceuticalsCompany annual report on formDrug administrationStern investor relations incExchange commissionSecurities exchangeUs food drug administrationChief executive officerRecent companySupplemental new drug applicationWorld sleepThird quarterOrphan drug exclusivity